tirzepatide (Mounjaro)

---

Tirzepatide (Mounjaro) is an FDA-approved weekly injection used for type 2 diabetes to lower blood sugar and useful for weight loss.Tirzepatide works by activating the GIP and GLP-1 receptors. Tirzepatide is only indicated for adults and should be used along with diet and exercise. 

Tirzepatide works to decrease blood sugar levels by increasing insulin production and also lowering the amount of sugar the liver makes. It also slows the rate food passes through your body which makes you feel full longer, and this may be one of the ways it may help weight loss.

Tirzepatide is a GIP/GLP-1 receptor agonist, which means it works on the glucose-dependent insulinotropic polypeptide (GIP) receptors and the glucagon-like peptide-1 (GLP-1) receptors.

Tirzepatide can be used as a single therapy (on its own) or with other diabetes medicines, including sulfonylureas, SGLT2 inhibitors or metformin.